JREU:F:F-JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 51.45

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.05 (+0.17%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.61 (+1.21%)

USD 112.01B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.26 (+0.05%)

USD 94.11B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.14 (+0.25%)

USD 93.50B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.55 (-0.23%)

USD 56.46B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.03 (+0.18%)

USD 52.79B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.03 (-0.03%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

+0.01 (+0.13%)

USD 39.38B
0ZC:F Zscaler Inc

-1.14 (-0.65%)

USD 37.92B

ETFs Containing JREU:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.09% 89% A- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.09% 87% B+ 71% C-
Trailing 12 Months  
Capital Gain 29.84% 85% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.84% 82% B 71% C-
Trailing 5 Years  
Capital Gain 117.78% 98% N/A 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 117.78% 98% N/A 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 16.50% 94% A 82% B
Dividend Return 16.50% 93% A 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.13% 39% F 73% C
Risk Adjusted Return 109.08% 99% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.